Trandafir M, Savu O, Pasarica D, Bleotu C, Gheorghiu M
Med Sci (Basel). 2024; 12(2).
PMID: 38921685
PMC: 11205729.
DOI: 10.3390/medsci12020031.
Piko N, Bevc S, Hojs R, Ekart R
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675379
PMC: 11054947.
DOI: 10.3390/ph17040418.
Wang N, Zhang C
Int J Mol Sci. 2024; 25(6).
PMID: 38542060
PMC: 10970506.
DOI: 10.3390/ijms25063086.
Jiang P, Yao C, Guo D
Acta Pharm Sin B. 2024; 14(1):38-66.
PMID: 38239236
PMC: 10793104.
DOI: 10.1016/j.apsb.2023.11.006.
Njeim R, Alkhansa S, Fornoni A
Pharmaceutics. 2023; 15(5).
PMID: 37242602
PMC: 10222020.
DOI: 10.3390/pharmaceutics15051360.
Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies.
Huang G, Zhang Y, Zhang Y, Ma Y
Biochem Biophys Rep. 2023; 33:101417.
PMID: 36620089
PMC: 9813680.
DOI: 10.1016/j.bbrep.2022.101417.
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis.
Ganugula R, Nuthalapati N, Dwivedi S, Zou D, Arora M, Friend R
J Control Release. 2022; 353:621-633.
PMID: 36503070
PMC: 9904426.
DOI: 10.1016/j.jconrel.2022.12.012.
Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions.
Boi R, Ebefors K, Henricsson M, Boren J, Nystrom J
Sci Rep. 2022; 12(1):7322.
PMID: 35513427
PMC: 9072365.
DOI: 10.1038/s41598-022-10907-4.
TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy.
Shen J, Dai Z, Li Y, Zhu H, Zhao L
Diabetol Metab Syndr. 2022; 14(1):26.
PMID: 35120573
PMC: 8815223.
DOI: 10.1186/s13098-021-00780-y.
Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy.
Ying C, Zhou Z, Dai J, Wang M, Xiang J, Sun D
Inflamm Res. 2022; 71(2):191-204.
PMID: 35028708
DOI: 10.1007/s00011-021-01532-4.
miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1.
Sheng S, Zou M, Yang Y, Guan M, Ren S, Wang X
In Vitro Cell Dev Biol Anim. 2021; 57(8):763-774.
PMID: 34608568
PMC: 8585819.
DOI: 10.1007/s11626-021-00606-1.
Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway.
Han J, Pang X, Zhang Y, Peng Z, Shi X, Xing Y
Drug Des Devel Ther. 2020; 14:3223-3234.
PMID: 32848363
PMC: 7425656.
DOI: 10.2147/DDDT.S257613.
The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders.
Menini S, Iacobini C, Vitale M, Pugliese G
Cells. 2020; 9(8).
PMID: 32751658
PMC: 7464565.
DOI: 10.3390/cells9081812.
AEG-1 aggravates inflammation via promoting NALP3 inflammasome formation in murine endometriosis lesions.
Zhao J, Ma W, Chen W, Gao J, Li C, Tong Y
Anim Cells Syst (Seoul). 2019; 23(6):407-413.
PMID: 31853378
PMC: 6913626.
DOI: 10.1080/19768354.2019.1691052.
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
Zhang C, Zhu X, Li L, Ma T, Shi M, Yang Y
Diabetes Metab Syndr Obes. 2019; 12:1297-1309.
PMID: 31447572
PMC: 6684489.
DOI: 10.2147/DMSO.S199802.
Kidney Disease in Diabetes Mellitus: Cross-Linking between Hyperglycemia, Redox Imbalance and Inflammation.
Amorim R, Guedes G, Vasconcelos S, Santos J
Arq Bras Cardiol. 2019; 112(5):577-587.
PMID: 31188964
PMC: 6555585.
DOI: 10.5935/abc.20190077.
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.
Sharma A, Tate M, Mathew G, Vince J, Ritchie R, de Haan J
Front Physiol. 2018; 9:114.
PMID: 29515457
PMC: 5826188.
DOI: 10.3389/fphys.2018.00114.
Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S, Li Y, Fan J, Zhang X, Luan J, Bian Q
Cell Death Dis. 2017; 8(7):e2937.
PMID: 28726774
PMC: 5550847.
DOI: 10.1038/cddis.2017.292.
Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.
Lee E, Lee M, Kwon M, Kim H, Kang J, Kim Y
PLoS One. 2017; 12(6):e0179221.
PMID: 28640832
PMC: 5480859.
DOI: 10.1371/journal.pone.0179221.
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H, Peng R, Zhang L, Sun Y, Peng H, Liu H
Cell Death Dis. 2017; 8(2):e2583.
PMID: 28151474
PMC: 5386454.
DOI: 10.1038/cddis.2016.451.